Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class small molecule product candidates with broad potential benefit to patients
Science
Modulating validated and new pathways to develop novel therapeutics
News
September 19,
2023
Tempest Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development
September 5,
2023
Tempest to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 10,
2023
Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
Events
Monday,
September 11TH,
2023
at
7:00 AM
Eastern
H.C. Wainwright 25th Annual Global Investment Conference
Listen: Webcast
Wednesday,
June 7TH,
2023
at
2:00 PM
Eastern
Jefferies Global Healthcare Conference
Listen: Webcast
Sunday,
June 5TH,
2022
at
7:30 AM
Eastern
Tempest Investor Breakfast at 2022 ASCO Annual Meeting
Listen: Webcast
Download: Tempest Investor Breakfast at 2022 ASCO Annual Meeting Presentation [pdf]
Monday,
March 29TH,
2021
at
8:30 AM
Eastern
Tempest and Millendo Proposed Merger Investor Call
Listen: Webcast
Download: Proposed Merger of Tempest and Millendo [pdf]